About Prime Global
Who are we?
We provide clients with scientific and creative expertise in all key therapy areas, as well as specialist experience in rare and ultra-rare diseases. We provide medical communications, evidence and market access, and patient engagement services to pharmaceutical and biotech companies around the world.
Our highly qualified teams provide expertise across a wide range of therapy areas, including rare and ultra-rare diseases, and add value across all stages of the therapeutic agent lifecycle, from preclinical to mature products.
We believe passionately in the value of innovative and creative science communication to further our understanding of the world, and to benefit patients everywhere.
What are we doing for rare disease day?
We want to celebrate the work we do around rare and ultra-rare diseases, find out more from colleagues, clients and friends who live and work with rare diseases, and share knowledge and expertise in this field.
Our Patient Team will be delivering a series of blogs and social media posts exploring the patient engagement considerations in the rare disease space.
Working and living with rare diseases isn’t just a one-day thing; we are also using the day as a kick-off to a continuing series of lunch and learn sessions. We will be holding our first ‘lunch and learn’ session with Jamie O’Hara. Jamie is the CEO of our recent acquisition, HCD Economics, as well as being the Chair of the Rare Disease Special Interest Group at ISPOR.